News

Aldehydes inhibitor may help protect stem cells

What are aldehydes and what do they do?  Research has shown that small molecules called aldehydes cause DNA damage and increase the potential for bone marrow failure. Aldehydes are formed within our bodies (endogenous) and from sources outside our bodies...

Read More >

30th T-Shirt Contest: VOTE NOW!

We asked the FA community to help design FARF’s 30th anniversary t-shirt. You all responded with some fantastic entries. We have narrowed down the submissions to six finalists, and now the voting turns to YOU. Please look at each of...

Read More >

Show Us How You FA

FA families started FA Day 10 years ago to raise funds for research & family support services. We know that longer and better lives for people with FA are possible when we all get involved. #ThisIsHowIFA reflects the many people it...

Read More >

How might we apply cancer-fighting strategies from the general population to the FA population?

To fast-track therapies for people with Fanconi anemia (FA), it’s often best to start by examining progress that’s already been made in the general population. Large-scale studies such as The Cancer Genome Atlas (TCGA) have made it possible to detect...

Read More >

News from the lab: the FA pathway and fertility

An update for FA families In the March 2019 issue of Trends in Genetics, researchers from St. Vincent’s Institute in Australia published a paper on the FA pathway and fertility. We asked the authors to provide a summary for FA families....

Read More >

Update: the FANCA Gene Therapy Trial

The global Fanconi anemia gene therapy program is now open in the USA and Europe. In Europe, a new study, known as FANCOLEN-2, is available at CIEMAT/Hospital del Niño Jesús in Madrid, Spain. In the USA, a similar study is now...

Read More >